RA patients with periodontitis on DMARDs have been found to exhibit lower local IL-1β, IL-4, and TNF-α levels than otherwise healthy patients with periodontitis [16], however, the study about the effect of DMARDs on clinical periodontal parameters is limited. This evidence concerns the gene TNF and rheumatoid arthritis.